Maccura Biotechnology Co.Ltd (SHE:300463)
China flag China · Delayed Price · Currency is CNY
10.28
+0.02 (0.19%)
May 19, 2026, 10:32 AM CST

SHE:300463 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
720.46667.19671.45835.96587.35637.16
Trading Asset Securities
47.0250.1860.06311.14663.72-
Cash & Short-Term Investments
767.48717.36731.521,1471,251637.16
Cash Growth
-0.60%-1.93%-36.23%-8.31%96.35%4.10%
Accounts Receivable
1,0661,1541,5891,8342,1361,924
Other Receivables
108.25103.0923.327.6519.4121.61
Receivables
1,1741,2571,6131,8612,1551,946
Inventory
893.16849.13901.58907.491,0391,076
Other Current Assets
364.61404.09393.84306.33251.87195.77
Total Current Assets
3,1993,2283,6404,2224,6983,855
Property, Plant & Equipment
3,8293,8123,4072,9292,5132,015
Long-Term Investments
145.68145.68173.93172.73193.81144.12
Goodwill
51.0451.0451.04145.15145.1521.32
Other Intangible Assets
392.76402.1375.16283.25269.37194.61
Long-Term Deferred Tax Assets
157.76158.86133.78153.86161.45161.18
Long-Term Deferred Charges
138.86119.2119.6142.4113.4295.51
Other Long-Term Assets
77.0777.5975.7170.1974.4579.77
Total Assets
7,9917,9957,9768,1198,1686,567
Accounts Payable
195.01208.67316.75365.85380.89317.43
Accrued Expenses
64.5197.11136.39136.86152.61131.59
Short-Term Debt
249.25258.96255.1144.65248.08530.56
Current Portion of Long-Term Debt
165.14161.14202.42330.56139.1130
Current Portion of Leases
--8.8614.4813.213.64
Current Income Taxes Payable
7.369.55.6919.3139.8423.6
Current Unearned Revenue
113.41100.1872.0472.3674.4177
Other Current Liabilities
217.16217.81198.7136.5435.2289.35
Total Current Liabilities
1,0121,0531,1961,1211,0831,313
Long-Term Debt
555.77521.87184.12162.5285.8424.1
Long-Term Leases
4.374.36.7912.9815.0417.15
Long-Term Unearned Revenue
25.7224.6923.8328.831.0728.1
Long-Term Deferred Tax Liabilities
74.2277.92134179.07223.72242.65
Other Long-Term Liabilities
6.56.757.943.83--
Total Liabilities
1,6781,6891,5531,5081,6392,025
Common Stock
604.67604.67612.47612.47612.47556.47
Additional Paid-In Capital
1,5921,5921,7831,7811,781279.51
Retained Earnings
4,0894,0804,1794,1474,0473,624
Treasury Stock
---220.24-170.18-170.18-170.18
Comprehensive Income & Other
-1.05-1.0714.1814.8923.298.34
Total Common Equity
6,2856,2766,3696,3856,2934,299
Minority Interest
27.6530.0354.61226.64236.25243.16
Shareholders' Equity
6,3126,3066,4246,6116,5294,542
Total Liabilities & Equity
7,9917,9957,9768,1198,1686,567
Total Debt
974.54946.27657.29665.17701.221,115
Net Cash (Debt)
-207.06-228.974.23481.94549.84-478.29
Net Cash Growth
---84.60%-12.35%--
Net Cash Per Share
-0.34-0.380.120.790.90-0.86
Filing Date Shares Outstanding
603.09579.86608.51606.83612.47556.47
Total Common Shares Outstanding
603.09579.86608.51606.83612.47556.47
Working Capital
2,1872,1752,4443,1023,6142,542
Book Value Per Share
10.4210.8210.4710.5210.277.72
Tangible Book Value
5,8415,8235,9435,9565,8794,083
Tangible Book Value Per Share
9.6810.049.779.829.607.34
Buildings
--783.53783.35739.86732.5
Machinery
--2,5082,3041,9931,808
Construction In Progress
--1,103714.48504.0176.97
Source: S&P Global Market Intelligence. Standard template. Financial Sources.